TRVI logo

Trevi Therapeutics, Inc. (TRVI) Selling, general & administrative expenses

annual SGA:

$0.00-$10.24M(-100.00%)
December 31, 2024

Summary

  • As of today (September 16, 2025), TRVI annual SGA is $0.00, with the most recent change of -$10.24 million (-100.00%) on December 31, 2024.
  • During the last 3 years, TRVI annual SGA has fallen by -$9.49 million (-100.00%).
  • TRVI annual SGA is now -100.00% below its all-time high of $10.24 million, reached on December 31, 2023.

Performance

TRVI SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRVIincome statement metrics

quarterly SGA:

$0.00-$3.66M(-100.00%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TRVI quarterly SGA is $0.00, with the most recent change of -$3.66 million (-100.00%) on June 30, 2025.
  • Over the past year, TRVI quarterly SGA has dropped by -$3.27 million (-100.00%).
  • TRVI quarterly SGA is now -100.00% below its all-time high of $3.66 million, reached on March 31, 2025.

Performance

TRVI quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRVIincome statement metrics

TTM SGA:

-$1.17B-$47.30M(-4.21%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TRVI TTM SGA is -$1.17 billion, with the most recent change of -$47.30 million (-4.21%) on June 30, 2025.
  • Over the past year, TRVI TTM SGA has dropped by -$1.18 billion (-10265.52%).
  • TRVI TTM SGA is now -1285.43% below its all-time high of -$84.43 million.

Performance

TRVI TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRVIincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

TRVI Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-100.0%-100.0%-10000.0%
3 y3 years-100.0%-100.0%-10000.0%
5 y5 years-100.0%-100.0%-10000.0%

TRVI Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-100.0%at low-100.0%at low-58.5%at low
5 y5-year-100.0%at low-100.0%at low-146.4%at low
alltimeall time-100.0%at low-100.0%at low-1285.4%at low

TRVI Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$0.00(-100.0%)
$6.52M(-33.4%)
Mar 2025
-
$3.66M(>+9900.0%)
$9.79M(+6.0%)
Dec 2024
$0.00(-100.0%)
$0.00(-100.0%)
$9.23M(-20.7%)
Sep 2024
-
$2.86M(-12.4%)
$11.65M(+1.2%)
Jun 2024
-
$3.27M(+5.4%)
$11.51M(+6.8%)
Mar 2024
-
$3.10M(+28.4%)
$10.78M(+5.3%)
Dec 2023
$10.24M(+1.7%)
$2.42M(-11.3%)
$10.24M(+0.7%)
Sep 2023
-
$2.72M(+7.2%)
$10.16M(+0.9%)
Jun 2023
-
$2.54M(-0.9%)
$10.08M(-1.7%)
Mar 2023
-
$2.56M(+9.5%)
$10.26M(+1.8%)
Dec 2022
$10.07M(+6.1%)
$2.34M(-11.2%)
$10.07M(+2.5%)
Sep 2022
-
$2.64M(-3.0%)
$9.83M(+4.3%)
Jun 2022
-
$2.72M(+14.2%)
$9.42M(+0.5%)
Mar 2022
-
$2.38M(+13.7%)
$9.37M(-1.3%)
Dec 2021
$9.49M
$2.09M(-6.1%)
$9.49M(-5.4%)
DateAnnualQuarterlyTTM
Sep 2021
-
$2.23M(-16.5%)
$10.03M(-1.8%)
Jun 2021
-
$2.67M(+6.8%)
$10.22M(+1.8%)
Mar 2021
-
$2.50M(-5.1%)
$10.04M(-1.2%)
Dec 2020
$10.16M(+39.1%)
$2.63M(+9.0%)
$10.16M(+7.3%)
Sep 2020
-
$2.42M(-3.0%)
$9.47M(+4.6%)
Jun 2020
-
$2.49M(-4.9%)
$9.05M(+7.1%)
Mar 2020
-
$2.62M(+34.8%)
$8.45M(+15.7%)
Dec 2019
$7.31M(+68.5%)
$1.94M(-2.9%)
$7.31M(+7.9%)
Sep 2019
-
$2.00M(+5.9%)
$6.77M(+41.9%)
Jun 2019
-
$1.89M(+28.2%)
$4.77M(+24.8%)
Mar 2019
-
$1.47M(+4.8%)
$3.82M(+62.8%)
Dec 2018
$4.34M(>+9900.0%)
$1.41M(+49.4%)
$2.35M(+50.0%)
Jun 2018
-
$941.00K(+50.8%)
$1.56M(+150.8%)
Dec 2017
$0.00(-100.0%)
-
-
Dec 2017
-
$624.00K
$624.00K
Dec 2016
$1.71M
-
-

FAQ

  • What is Trevi Therapeutics, Inc. annual SGA?
  • What is the all time high annual SGA for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. annual SGA year-on-year change?
  • What is Trevi Therapeutics, Inc. quarterly SGA?
  • What is the all time high quarterly SGA for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. quarterly SGA year-on-year change?
  • What is Trevi Therapeutics, Inc. TTM SGA?
  • What is the all time high TTM SGA for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. TTM SGA year-on-year change?

What is Trevi Therapeutics, Inc. annual SGA?

The current annual SGA of TRVI is $0.00

What is the all time high annual SGA for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high annual SGA is $10.24M

What is Trevi Therapeutics, Inc. annual SGA year-on-year change?

Over the past year, TRVI annual SGA has changed by -$10.24M (-100.00%)

What is Trevi Therapeutics, Inc. quarterly SGA?

The current quarterly SGA of TRVI is $0.00

What is the all time high quarterly SGA for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high quarterly SGA is $3.66M

What is Trevi Therapeutics, Inc. quarterly SGA year-on-year change?

Over the past year, TRVI quarterly SGA has changed by -$3.27M (-100.00%)

What is Trevi Therapeutics, Inc. TTM SGA?

The current TTM SGA of TRVI is -$1.17B

What is the all time high TTM SGA for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high TTM SGA is -$84.43M

What is Trevi Therapeutics, Inc. TTM SGA year-on-year change?

Over the past year, TRVI TTM SGA has changed by -$1.18B (-10265.52%)
On this page